Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2

COVID-19, caused by the coronavirus SARS-CoV-2, represents a serious worldwide health issue, with continually emerging new variants challenging current therapeutics. One promising alternate therapeutic avenue is represented by nanobodies, small single-chain antibodies derived from camelids with nume...

Descripción completa

Detalles Bibliográficos
Autores principales: Cross, Frederick R., Fridy, Peter C., Ketaren, Natalia E., Mast, Fred D., Li, Song, Olivier, J. Paul, Pecani, Kresti, Chait, Brian T., Aitchison, John D., Rout, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884143/
https://www.ncbi.nlm.nih.gov/pubmed/36720309
http://dx.doi.org/10.1016/j.jbc.2023.102954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884143/
https://www.ncbi.nlm.nih.gov/pubmed/36720309
http://dx.doi.org/10.1016/j.jbc.2023.102954

Ejemplares similares